Dynamic Advisor Solutions LLC Rigel Pharmaceuticals Inc Transaction History

Dynamic Advisor Solutions LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	SELL	$0.72 - $1.56 $1,440 - $3,120	-2,000 Reduced 8.59%	21,289 $30,000
Q3 2023 Oct 10, 2023	BUY	$1.07 - $1.39 $3,210 - $4,170	3,000 Added 14.79%	23,289 $25,000
Q2 2023 Aug 03, 2023	SELL	$1.12 - $1.82 $568 - $924	-508 Reduced 2.44%	20,289 $26,000
Q1 2023 Apr 10, 2023	SELL	$1.25 - $2.0 $2,503 - $4,006	-2,003 Reduced 8.79%	20,797 $27,000
Q4 2022 Jan 12, 2023	BUY	$0.67 - $11.9 $4,355 - $77,350	6,500 Added 39.88%	22,800 $0
Q3 2022 Oct 20, 2022	SELL	$1.1 - $12.2 $5,500 - $61,000	-5,000 Reduced 23.47%	16,300 $19,000
Q4 2021 Jan 26, 2022	SELL	$2.36 - $3.57 $2,360 - $3,570	-1,000 Reduced 4.48%	21,300 $56,000
Q3 2021 Oct 28, 2021	BUY	$3.5 - $4.5 $3,500 - $4,500	1,000 Added 4.69%	22,300 $81,000
Q2 2021 Aug 10, 2021	BUY	$3.09 - $4.54 $12,360 - $18,160	4,000 Added 23.12%	21,300 $92,000
Q1 2021 Apr 27, 2021	SELL	$3.35 - $4.93 $10,050 - $14,790	-3,000 Reduced 14.78%	17,300 $59,000
Q4 2020 Feb 03, 2021	SELL	$2.35 - $3.74 $3,689 - $5,871	-1,570 Reduced 7.18%	20,300 $71,000
Q3 2020 Oct 27, 2020	BUY	$1.78 - $4.13 $38,928 - $90,323	21,870 New	21,870 $52,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Dynamic Advisor Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Dynamic Advisor Solutions LLC with notifications on news.